Technology. Intelligence. Strategic growth.

Laboratory Technology & Digital Transformation

Clarify where technology can strengthen your business — and build a practical roadmap for platforms, workflows and digital investment.

Who it's for

Laboratory leadership teams modernizing operations, technology companies refining their platform strategy, and suppliers connecting instruments, software and services.

Typically includes

• Business objectives and current-workflow assessment
• LIMS, ELN, software and platform strategy
• Build, buy or partner decision criteria
• Integration, adoption and change-management priorities
• Vendor evaluation questions and a phased investment roadmap

Strategic advisory, not a claim of software implementation or systems integration. Technical delivery is scoped separately with the appropriate specialists.

Relevant sectors: Testing & Analytical Laboratories, Research & Biotech, CDMOs & Laboratory Service Providers, Materials & Industrial Laboratories, Life Science Equipment & Suppliers, Laboratory Software & LIMS

AI & Data Intelligence Strategy

Evaluate AI and data opportunities through a commercial and operational lens — with clear use cases, governance questions and pilot priorities.

Who it's for

Laboratories exploring data-led decision making, software companies evaluating AI-enabled products, and investors assessing an AI or data proposition in the laboratory sector.

Typically includes

• Business-use-case discovery and prioritization
• Data availability, ownership and governance questions
• Pilot scope, decision criteria and value assumptions
• Vendor and partner evaluation from a business perspective
• Human oversight, adoption and risk questions for specialist review

Business strategy advisory; not model development, cybersecurity assurance or a guarantee of AI performance. Do not submit proprietary datasets through the inquiry form.

Relevant sectors: Investors & Acquirers, Diagnostics & Clinical Laboratories, Laboratory Software & LIMS

Strategic Partnerships & Alliances

Identifying, evaluating and opening the right partnerships for laboratories, diagnostics companies, laboratory software / LIMS vendors and life-sciences organizations.

Who it's for

Laboratories, diagnostics developers, LIMS and laboratory-software companies, instrument suppliers, CDMOs, CROs and life-sciences firms seeking distribution, referral, technology or co-development partners.

Typically includes

• Partner landscape mapping across laboratory, diagnostic, software and supplier segments
• Partner fit criteria: capability, quality posture, customer overlap and incentives
• Counterparty outreach strategy and first-conversation preparation; introductions where appropriate
• Alliance models: referral, reseller, co-marketing, integration and co-development
• Go-to-market, positioning and business-development strategy around the partnership
• Governance and review cadence once a partnership is live

Advisory and introductions only; no partnership outcome is guaranteed. Contracts are negotiated with the client's own counsel.

Relevant sectors: Testing & Analytical Laboratories, Research & Biotech, CDMOs & Laboratory Service Providers, Materials & Industrial Laboratories, Life Science Equipment & Suppliers

Financing Readiness & Investment Diligence Reviews

Evaluate a laboratory-sector business, technology proposition or investment case before committing capital — with a focused review of commercial and operational assumptions.

Who it's for

Founders preparing to approach lenders, grant bodies or investors, and investors, family offices or acquirers evaluating a laboratory-sector opportunity.

Typically includes

• Business-model and commercial-assumption review from an operator's perspective
• Platform differentiation, customer adoption and data-dependency questions
• Readiness of the narrative, data room topics and management answers
• Operational and market red flags worth investigating further
• Technology, integration and regulatory dependencies for specialist diligence

Business advisory only. This is not investment, securities, legal, tax or accounting advice; Laboratory Advisory does not solicit investors, sell securities or handle funds. No financing outcome is guaranteed.

Relevant sectors: Investors & Acquirers, Laboratory Software & LIMS

Operational & Commercial Audits

A structured, candid assessment of how a laboratory or laboratory-facing business runs and sells — with prioritized recommendations.

Who it's for

Owners and boards who sense growth has stalled, margins are thin or the commercial engine depends too heavily on a few people.

Typically includes

• Pricing, service mix and capacity utilization review
• Sales, marketing and business-development process assessment
• Customer concentration and channel dependence
• Digital workflows, information visibility and decision ownership
• Prioritized findings and a practical 90-day action plan

Relevant sectors:

Fractional Executive Management

Part-time or interim senior commercial and strategic leadership for organizations that need experienced direction without a full-time hire.

Who it's for

Laboratories, diagnostics and laboratory-software companies between leaders, entering new markets, or needing focused growth leadership for a defined period.

Typically includes

• Defined strategic, commercial, technology-program or partnerships leadership
• Interim commercial leadership during transitions
• Project-based leadership with defined scope and deliverables
• Building the plan, team and handover for a permanent hire

Contract advisory roles defined case by case. Scope, title and authority are agreed in writing; no outcome is guaranteed.

Relevant sectors:

Turnaround & Restructuring Support

Steady, practical support for laboratory businesses under commercial, operational or compliance pressure.

Who it's for

Owners, boards and investors of laboratories or laboratory-facing companies facing declining revenue, a lost key customer, compliance findings or leadership gaps.

Typically includes

• Rapid situation assessment: commercial, operational and quality
• Stabilization priorities and stakeholder communication planning
• Service-line, customer and cost focus decisions
• Coordination with the client's legal, financial and restructuring professionals

Operational advisory only. Formal insolvency, legal and financial restructuring work must be performed by appropriately licensed professionals.

Relevant sectors:

M&A Evaluation

Evaluate strategic fit, commercial readiness and integration priorities for laboratory, software and technology transactions — before committing to the next step.

Who it's for

Laboratory owners planning succession or exit, and strategic or financial acquirers exploring laboratory, diagnostics or laboratory-software targets.

Typically includes

• Market mapping of segments and potential counterparties
• Commercial, platform, data and operational diligence priorities
• Strategic-fit assessment: customers, capabilities, technology and integration
• Confidential buyer and seller introductions where appropriate
• Coordination alongside licensed advisors, attorneys and accountants

Advisory and introductions only. Laboratory Advisory does not act as a licensed business or securities broker, does not hold client funds, and cannot guarantee any transaction will occur or close.

Relevant sectors: Investors & Acquirers, Testing & Analytical Laboratories, CDMOs & Laboratory Service Providers, Materials & Industrial Laboratories, Laboratory Software & LIMS

Commercialization & Scientist to CEO

Translate scientific and technology capability into a focused market proposition, a commercial plan and the leadership decisions needed to build the business.

Who it's for

Scientist-founders, diagnostic developers and owner-operators of testing, research and service laboratories, from pre-launch to established.

Typically includes

• Go-to-market strategy, pricing and service positioning
• Capacity utilization and throughput economics
• Strategic sales: target accounts, pipeline and partnerships
• Hiring and building a leadership bench beyond the founder
• Software, platform and technology commercialization priorities
• Financing options and exit readiness

Advisory and coaching only — not legal, financial, investment or tax advice; no funding, accreditation or transaction outcome is guaranteed.

Relevant sectors: Research & Biotech, Diagnostics & Clinical Laboratories, Life Science Equipment & Suppliers

FDA Regulatory & Quality Strategy

Focused regulatory and quality strategy for organizations navigating FDA readiness, inspection questions and the operating requirements around growth.

Who it's for

Laboratories, diagnostics developers and manufacturers in FDA-regulated or accredited environments, and organizations preparing for inspection or audit.

Typically includes

• Regulatory pathway strategy discussions alongside regulatory counsel
• Inspection readiness and mock-inspection perspective
• Quality-system gap reviews
• Response strategy for inspectional observations
• Supplier and contract laboratory qualification considerations

Strategic advisory; not legal advice. No inspection or regulatory outcome is guaranteed.

Relevant sectors: Diagnostics & Clinical Laboratories